Canadian application, no grantCanada
Prognosis of cancer patients by determining expression of cell cycle regulators p27 and cyclin e
CA 2279361 A1 · Owner: Fred Hutchinson Cancer Research Center · Inventors: Porter, Peggy L.; Roberts, James M.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The subject invention provides methods for determining the prognosis for cancer patients and for staging cancer by analyzing tumor samples to determine the levels of both cyclin E and p27-kipl.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 29, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 29, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 29, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 29, 1998
GrantedNo grant recorded
Term endedJanuary 29, 2018
Patent numberCA 2279361 A1
Classification (IPC)G01N33/48
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.